What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Statistics
Brian Hutton spends much of his time researching Internal medicine, Meta-analysis, Nuclear medicine, Randomized controlled trial and Imaging phantom.
Brian Hutton has included themes like Diabetes mellitus, Psychiatry, Oncology and Cardiology in his Internal medicine study.
His Meta-analysis study combines topics from a wide range of disciplines, such as Psychological intervention, Quality of life, Relative risk, Telehealth and Intensive care medicine.
His work deals with themes such as Tomography and Radiology, which intersect with Nuclear medicine.
His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Adjuvant, Systematic review, Antibody and Comparative effectiveness research.
His study on Meta-Analysis as Topic is often connected to Universal language as part of broader study in Systematic review.
His most cited work include:
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (1949 citations)
- A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology (523 citations)
- The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. (478 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Randomized controlled trial, Meta-analysis, Nuclear medicine and Iterative reconstruction.
He has researched Internal medicine in several fields, including Surgery and Oncology.
Brian Hutton interconnects Placebo, Systematic review, Clinical trial and Physical therapy in the investigation of issues within Randomized controlled trial.
His study looks at the relationship between Systematic review and fields such as Psychological intervention, as well as how they intersect with chemical problems.
His Meta-analysis study incorporates themes from Observational study and Intensive care medicine.
His study in Nuclear medicine is interdisciplinary in nature, drawing from both Tomography, Radiology and Lung.
He most often published in these fields:
- Internal medicine (30.89%)
- Randomized controlled trial (24.25%)
- Meta-analysis (21.54%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (30.89%)
- Randomized controlled trial (24.25%)
- Systematic review (17.07%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Randomized controlled trial, Systematic review, Meta-analysis and Breast cancer are his primary areas of study.
Internal medicine and Oncology are frequently intertwined in his study.
The Randomized controlled trial study combines topics in areas such as Premedication, Cohort study, Adverse effect, Dexamethasone and Docetaxel.
His work carried out in the field of Systematic review brings together such families of science as Psychological intervention, Cochrane Library, Family medicine and Intensive care medicine.
His Psychological intervention research includes elements of Pediatrics and Protocol.
His Meta-analysis research is multidisciplinary, relying on both Stroke, Venous thromboembolism and Cancer.
Between 2018 and 2021, his most popular works were:
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis (46 citations)
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis (46 citations)
- Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis. (37 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Statistics
Brian Hutton focuses on Internal medicine, Systematic review, Meta-analysis, Cochrane Library and Randomized controlled trial.
Internal medicine is often connected to Oncology in his work.
His studies deal with areas such as Psychological intervention, Solid organ transplantation, Guideline, Intensive care medicine and Evidence-based medicine as well as Systematic review.
His studies in Meta-analysis integrate themes in fields like Moderate to severe, Psoriasis, Plaque psoriasis, Induction Phase and Relative efficacy.
His Cochrane Library research incorporates themes from Placebo, Adverse effect and Family medicine.
The concepts of his Randomized controlled trial study are interwoven with issues in Relative risk, Clinical trial, Radiation therapy and Chronic pain.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
